Outcome of QIP committee meeting of Suven Life Sciences

Held on 27 November 2014

Suven Life Sciences announced that subsequent to the approval accorded by the Board of Directors of the Company, at its meeting held on 22 September 2014 and the approval of the shareholders of the Company by way of a special resolution dated 21 October 2014 for the QIP, the QIP Committee of the Company i.e. 27 November 2014 has, inter alia passed the following resolutions:

a. Authorizing the opening of the QIP on 27 November 2014;

b. Approving the Preliminary Placement Document dated 27 November 2014 in connection with the QIP, (the "Preliminary Placement Document"); and

c. Approval of the floor price for the QIP.

Further, the 'Relevant Date' for this purpose, in terms of Regulation 81(c) (i) of the SEBI ICDR Regulations, is 27 November 2014 and accordingly the floor price in respect of the aforesaid QIP, based on the pricing formula as prescribed under Regulation 85(1) of the SEBI ICDR Regulations is Rs. 201.38 per Equity Share. Pursuant to Regulation 85 of the SEBI ICDR Regulations, and further to the shareholder resolution dated 21 October 2014, the Company may offer a discount of not more than 5% on the floor price so calculated for the QIP.

Powered by Capital Market - Live News